Y.D. More Investments Ltd lowered its position in DarioHealth Corp. (NASDAQ:DRIO – Free Report) by 18.5% in the second quarter, HoldingsChannel reports. The fund owned 980,807 shares of the company’s stock after selling 221,924 shares during the quarter. Y.D. More Investments Ltd’s holdings in DarioHealth were worth $1,167,000 at the end of the most recent reporting period.
Separately, Clarity Capital Partners LLC purchased a new position in shares of DarioHealth in the 4th quarter valued at about $293,000. Institutional investors own 33.39% of the company’s stock.
DarioHealth Stock Performance
Shares of DRIO stock opened at $0.79 on Thursday. The company has a current ratio of 2.26, a quick ratio of 1.96 and a debt-to-equity ratio of 0.34. DarioHealth Corp. has a 12-month low of $0.68 and a 12-month high of $3.49. The business’s 50 day moving average is $1.03 and its two-hundred day moving average is $1.32. The company has a market capitalization of $23.64 million, a P/E ratio of -0.47 and a beta of 1.46.
DarioHealth Profile
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Featured Articles
- Five stocks we like better than DarioHealth
- The Basics of Support and Resistance
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- Retail Stocks Investing, Explained
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- Most Volatile Stocks, What Investors Need to Know
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Want to see what other hedge funds are holding DRIO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DarioHealth Corp. (NASDAQ:DRIO – Free Report).
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.